noel.terry@gmail.com
-
HBVZ10 exhibits robust in vivo potency and synergizes with entecavir to drive efficient cccDNA elimination and HBsAg seroclearance
Bai-Hua Zhang, Yuanping Zhou , Yukun Wu , Stephen Horrigan, Laura Luckenbaugh Jianming Hu, Fabien Zoulim, Yong-Yuan Zhang
-
HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination
Bai-Hua Zhang, Yuanping Zhou, Stephen Horrigan, Laura Luckenbaugh, Jianming Hu, Fabien Zoulim, and Yong-Yuan Zhang
-
Replication-driven HBV cccDNA loss in chimeric mice with humanized livers
Bai-Hua Zhang, Yuanping Zhou, Stephen Horrigan, Fabien Zoulim, Jianming Hu, Yong-Yuan Zhang
-
Optimizing HBV Combination Therapy: Dual Targeting of Intracellular Replication and Extracellular Virions with Entecavir and HBVZ10
Bai-Hua Zhang, Yuanping Zhou, Stephen Horrigan, Jianming Hu, Fabien Zoulim and Yong-Yuan Zhang
-
Heterogeneity of HBV-Infected Hepatocytes in Humanized Chimeric Mice Revealed by Single Cell Analyses Using FACS and Duplex Digital PCR
Bai-Hua Zhang, Yuanping Zhou, Stephen Horrigan, Fabien Zoulim, Jianming Hu and Yong-Yuan Zhang
-
Full Publication List
For Yong-Yuan Zhang, MD, PhD, Founder, Perpetuu
-
Engineering next-generation AAV capsids for liver-targeted gene therapy
Mi tincidunt elit, id quisque ligula ac diam, amet. Vel etiam suspendisse morbi eleifend faucibus eget vestibulum felis. Dictum quis montes, sit sit. Tellus aliquam enim urna, etiam. Mauris posuere vulputate arcu amet, vitae nisi, tellus tincidunt. At feugiat sapien varius id. Eget quis mi enim, leo lacinia pharetra, semper. Eget in volutpat mollis at…
-
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!